Cyclosporin A prodrugs: design, synthesis and biophysical properties

被引:27
作者
Hamel, AR [1 ]
Hubler, F [1 ]
Carrupt, A [1 ]
Wenger, RM [1 ]
Mutter, M [1 ]
机构
[1] Federal Inst Technol Lausanne, Inst Mol & Biol Chem, CH-1015 Lausanne, Switzerland
来源
JOURNAL OF PEPTIDE RESEARCH | 2004年 / 63卷 / 02期
关键词
cyclosporin A; diketopiperazine release; drug delivery; prodrugs; solubilization;
D O I
10.1111/j.1399-3011.2003.00111.x
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The cyclic undecapeptide cyclosporin A (CsA) has a remarkable spectrum of diverse biological activities, including anti-inflammatory, antifungal, antiparasitic as well as immunosuppressive activities. However, the low water solubility of this drug is a serious problem causing undesirable pharmacological properties such as erratic oral absorption. In order to overcome this problem, the design and synthesis of water-soluble prodrugs of CsA are described. Using the OH-MeBmt-1-group as attachment site, we investigate dipeptide systems exhibiting differential tendencies for intramolecular cyclization [diketopiperazine (DKP) formation] for tailoring the chemoreversible release of the parent CsA. In modulating the chemical and structural features of the dipeptide esters (N-alkylation, side chains, C-terminal Pro), we find conversion rates at physiological conditions ranging from minutes to several days. Together with their thermodynamic stability in the solid state and strongly enhanced solubility in water, these chemoreversible CsA prodrugs represent versatile candidates for therapeutical use.
引用
收藏
页码:147 / 154
页数:8
相关论文
共 26 条
[1]   MOLECULAR MECHANISMS OF IMMUNOSUPPRESSION [J].
BAUMANN, G ;
ZENKE, G ;
WENGER, R ;
HIESTAND, P ;
QUESNIAUX, V ;
ANDERSEN, E ;
SCHREIER, MH .
JOURNAL OF AUTOIMMUNITY, 1992, 5 :67-72
[2]   STEREOPOPULATION CONTROL .2. RATE ENHANCEMENT OF INTRAMOLECULAR NUCLEOPHILIC DISPLACEMENT [J].
BORCHARD.RT ;
COHEN, LA .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1972, 94 (26) :9166-9174
[3]  
BUNDGAARD H, 1991, Drugs of the Future, V16, P443
[4]  
DITTMANN J, 1994, J BIOL CHEM, V269, P2841
[5]  
DREWE J, 1992, BR J CLIN PHARM, P39
[6]   Cyclosporin -: An updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (Neoral®)1 in organ transplantation [J].
Dunn, CJ ;
Wagstaff, AJ ;
Perry, CM ;
Plosker, GL ;
Goa, KL .
DRUGS, 2001, 61 (13) :1957-2016
[7]   Diketopiperazines in peptide and combinatorial chemistry [J].
Fischer, PM .
JOURNAL OF PEPTIDE SCIENCE, 2003, 9 (01) :9-35
[8]   Kinetics of diketopiperazine formation using model peptides [J].
Goolcharran, C ;
Borchardt, RT .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 87 (03) :283-288
[9]   Crystal structure of calcineurin-cyclophilin-cyclosporin shows common but distinct recognition of immunophilin-drug complexes [J].
Huai, Q ;
Kim, HY ;
Liu, YD ;
Zhao, YD ;
Mondragon, A ;
Liu, JO ;
Ke, HM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (19) :12037-12042
[10]  
Kallen J., 1997, BIOTECHNOLOGY, V7, P535